Advertise here
Advertise here

Neville Robinson Rowell | The BMJ

Neville Rowell was a prominent figure in the field of dermatology, born and educated in Newcastle upon Tyne, where he worked at the Royal Victoria Infirmary before moving to Leeds. After obtaining membership in the Royal Colleges of Physicians, he became a consultant in 1961 and eventually headed the department in 1973. Neville worked tirelessly…

Read More

EU countries to push for outdoor smoking and vaping bans

EU countries are discussing stricter anti-smoking rules, including bans on smoking and vaping in outdoor areas like playgrounds and cafe patios. Health ministers from 27 nations will meet to address second-hand smoke and vapor exposure, with a non-binding recommendation likely to be approved. The proposal aims to reduce smoke-related deaths and ailments, extending restrictions to…

Read More

ADA Advises Against Using Compounded GLP-1 RA Medications

The American Diabetes Association (ADA) advises against using compounded versions of glucagon-like peptide 1 receptor agonist (GLP-1 RA) and dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 RA medications, due to safety concerns and potential dosing errors. They recommend using only FDA-approved versions of these medications for treating type 2 diabetes, reducing cardiovascular and kidney disease risk, and…

Read More

3 Innovations Philips Is Showcasing at RSNA 2024

The Radiological Society of North America is hosting its annual meeting in Chicago this week, featuring hundreds of companies showcasing the latest technology in the field. Philips announced an expanded partnership with AWS to move its integrated diagnostics portfolio to the cloud. They also introduced the BlueSeal MRI system that requires less helium and is…

Read More

VIDEO: ‘Provocative’ observational study assesses DMARD use in RA-ILD

. The study found that treatment with certain disease-modifying antirheumatic drugs, specifically methotrexate and TNF inhibitors, was associated with a reduced risk of developing interstitial lung disease in patients with rheumatoid arthritis. This highlights the potential benefits of these medications beyond managing joint symptoms. Sparks emphasizes the importance of further research to confirm these findings…

Read More

Sixty seconds on . . . asthma injections

Research published in Lancet Respiratory Medicine shows that benralizumab, a monoclonal antibody, significantly reduces asthma attacks and COPD exacerbations compared to prednisolone. This is the first new treatment for these conditions in 50 years, with experts believing it could be a game-changer. Benralizumab could benefit those with severe asthma or COPD, as it has shown…

Read More

Five new papers highlight cancer inequities, challenges and opportunities in South Asia

A series of five papers published in The Lancet Oncology by a University of Pittsburgh-led team highlights the challenges related to cancer control in SAARC countries and the Rohingya refugee population in Bangladesh. The papers underscore disparities in cancer outcomes, barriers to cancer care, and the need for actionable solutions to improve prevention, early detection,…

Read More

New study sheds light on the molecular basis of gene expression

An international research collaboration has made significant advances in understanding the molecular basis of gene expression. Using advanced microscopy techniques, the team observed how genetic information is translated into proteins at a detailed level. The study focused on how ribosomes find messenger RNA for protein synthesis, revealing a mechanism that aids in mRNA delivery to…

Read More

Accelerated Approval of New TKI Use in CML Sparks Questions

US regulators used a fast-track approval process for asciminib in the treatment of chronic myeloid leukemia (CML), despite its availability of existing medications. Asciminib is one of six tyrosine kinase inhibitors for CML and was granted accelerated approval for newly diagnosed patients. Concerns have been raised about the rapid approval process, with some questioning the…

Read More

Novartis Tries Again in Huntington’s, Putting Up $1B to Partner on a PTC Therapeutics Drug

PTC Therapeutics reported positive data for their Huntington’s disease drug, prompting Novartis to make a $1 billion upfront offer to license the drug. PTC will continue ongoing testing and lead discussions with the FDA, while Novartis will take over the pivotal study, manufacturing, and commercialization. The deal includes profit-sharing and milestone payments for PTC. The…

Read More

Homebound Seniors Living Alone Often Slip Through Health System’s Cracks

Carolyn Dickens, 76, a lung cancer survivor living in central Harlem, struggles with serious lung disease, high blood pressure, and regular fainting spells. She lives alone and is dangerously underweight. Across the country, over 2 million homebound seniors face similar challenges, with limited access to healthcare and social contact. Programs like Mount Sinai’s Visiting Doctors…

Read More

Study identifies strategies for racial, ethnic diversity in clinical trials

The TIDE-Asthma study focused on increasing diversity in clinical trial enrollment by targeting specific racial and ethnic groups. By implementing outreach strategies, including engaging key opinion leaders in diverse communities, the study exceeded its enrollment goals for Hispanic and Asian patients. The study aimed to assess the efficacy, safety, and tolerability of amlitelimab as an…

Read More

Supreme Court hears case on FDA regulation of vapes

The Supreme Court is hearing a case regarding the FDA’s decision to block flavored vaping products, which could change how the agency regulates tobacco. Two e-cigarette manufacturers sued the FDA after their marketing applications were denied, arguing that the agency changed its standards midway. The 5th U.S. Circuit Court of Appeals ruled against the FDA,…

Read More

An Imperfect Storm: a perfect story of an imperfect time

The book review highlights An Imperfect Storm by Chikwe and Vivianne Ihekweazu, emphasizing the need for African voices in storytelling, particularly in non-fiction and health literature. The authors provide a personal narrative of the Covid-19 pandemic, drawing from Chikwe Ihekweazu’s experience as an epidemiologist in Nigeria. The book offers insights into leadership, global health inequities,…

Read More

Impact of changes in gut environment on bacteria may help explain why we react differently to the same food

A study from the University of Copenhagen explores how changes in the gut environment impact gut bacteria, leading to differences in reactions to food. The research involved subjects swallowing a capsule to track pH, temperature, and pressure throughout the digestive system, revealing variations in gut transit time and environment. The findings suggest that individual differences…

Read More

Researchers discover new cause of cytokine storm in COVID-19

Researchers at multiple institutions found a novel cause of cytokine storm in COVID-19 patients, leading to increased risk of death. By analyzing the genomes of patients who died from COVID-19, they identified around 50 upregulated immune genes that play a role in the hyperinflammatory process. These genes, when overactivated, lead to cytokine storm syndrome and…

Read More

Novocure’s Pancreatic Cancer Treatment Meets Main Goal in Late-stage Study

Novocure’s experimental therapy using Tumor Treating Fields alongside chemotherapy showed positive results in extending the lives of patients with advanced pancreatic cancer in a late-stage trial. The therapy, which uses electric fields to target cancer cells while sparing healthy cells, helped patients live an average of 16.20 months compared to 14.16 months with chemotherapy alone….

Read More

Tackling Burnout: How AI Lifts the Coding Burden on Physicians

Physicians spend over three hours a day on documentation, often sacrificing personal time for paperwork. This results in significant costs to organizations and impacts physician satisfaction. Autonomous medical coding using AI technology is gaining traction as a solution to this burden. Physicians traditionally handle their own coding due to shortages in certified medical coders. The…

Read More

What is osteoporosis | Medical News Bulletin

Osteoporosis is a bone disease that causes bone weakness, affecting 1 in 4 women and 1 in 8 men over 50 in Canada. It causes fragile bones and increases the risk of fractures, with common ones being wrist, hip, and spinal fractures. Pain is usually not present until a fracture occurs, and hip fractures in…

Read More

Dermatologists view AI chatbots with both skepticism, potential

A study found that most dermatologists believe AI chatbots will be used in dermatology, with 76.5% of respondents agreeing. Concerns about misinformation and incorrect diagnoses were raised, but benefits such as administrative help were also acknowledged. Despite only 71.9% of physicians reporting using AI chatbots in practice, 76.5% believed it is somewhat or very likely…

Read More

Novartis back in Huntington’s with $1B licensing deal with PTC

Novartis has signed a licensing deal with PTC Therapeutics for an experimental Huntington’s disease treatment, with an upfront payment of $1 billion. The agreement also includes the potential for another $1.9 billion in payments based on hitting development, regulatory, and commercial milestones. Novartis CEO Vas Narasimhan stated that this deal aims to strengthen their neuroscience…

Read More

Education is essential for implementing the NHS workforce plan

Colin Macdougall and colleagues discuss the challenges facing the UK National Health Service, citing workforce shortages and a crisis in healthcare. The NHS published a long term workforce plan in 2023 with ambitious goals to address these issues, including increasing medical school places, general practitioner training places, nursing training places, and dentistry training places. The…

Read More

New Leukemia Txs, Fewer Blood Clots With GLP-1 Rxs

Groundbreaking studies on leukemia treatments and the effects of GLP-1 inhibitors on VTE risk will be presented at the ASH 2024 Annual Meeting. Research shows that adding blinatumomab to chemotherapy boosts disease-free survival in pediatric B-ALL patients, while eltrombopag is effective in treating severe pediatric ITP. Additionally, GLP-1 agonists may reduce the risk of VTE…

Read More

Depression May Trigger Severe Period Pain, Sleep Disturbances May Aggravate It: Study

A new study suggests that depression may actually trigger severe menstrual cramps, with sleep deprivation worsening their severity. Dysmenorrhea, or severe period pain, affects 15% of women and can be either primary or secondary. Research found a strong link between depression and primary dysmenorrhea in both European and East Asian populations, with sleep disturbances exacerbating…

Read More

Medicare Advantage fixes would regulate AI used to deny care

The Biden administration is pushing for Medicare to cover obesity drugs, but also proposing changes to private Medicare plans. The Centers for Medicare and Medicaid Services are suggesting technical and policy changes to Medicare Advantage and Part D plans for 2026. More than half of Medicare beneficiaries are enrolled in Medicare Advantage plans, but issues…

Read More

Gut transit time and pH shape microbiome individuality and dietary responses

A recent study published in Nature Microbiology investigated how gut transit time and pH affect variations in the human gut microbiome’s composition and metabolism. The study included 63 healthy participants and found significant variability in gut environment stability, with factors like stool moisture and pH influencing microbial composition and metabolic activity. Factors such as transit…

Read More

Which First-Line Treatments Are Most Cost-Effective?

A study evaluated the cost-effectiveness of different initial treatments for eosinophilic esophagitis (EoE), comparing proton pump inhibitor (PPI) therapy, swallowed topical corticosteroids (tCS), elimination diets, and the biologic dupilumab. Results showed that elimination diets were the most cost-effective option from a payer perspective, while PPI therapy was more cost-effective from a societal standpoint. Dupilumab would…

Read More

We’re reading about Medicare obesity coverage, a 340B analysis

The Biden administration is proposing Medicare and Medicaid coverage for weight loss drugs Wegovy and Zepbound, potentially costing $35 billion over a decade. Amgen’s obesity drug, MariTide, showed promising results with 20% weight loss in a Phase 2 study, leading to questions about its competitiveness. The results suggest MariTide could outperform other drugs like Wegovy…

Read More

HIV infections can be prevented—why some people act to protect themselves, and others don’t

The number of new HIV infections has decreased, but the impact on global health remains significant. In 2023, 1.3 million people acquired HIV, exceeding the target set by UNAids. Effective prevention methods like PrEp, condoms, vaginal rings, and injectables are available, but user decision-making plays a key role. A new framework called the decision cascade…

Read More

Neural connectivity predicts deep brain stimulation success in essential tremor

Groundbreaking research into thalamic connectivity is revolutionizing essential tremor treatment strategies, leading to more personalized and efficient deep brain stimulation (DBS) therapies. A recent study published in Brain highlights the intricate neural mechanisms involved in essential tremors, focusing on the cortical-thalamic-tremor network. By analyzing brain signals and tremor patterns, researchers identified specific connectivity patterns that…

Read More

Eating More Red Meat Could Increase Type 2 Diabetes Risk

Eating less red and processed meat may reduce the risk of developing type 2 diabetes and lower mortality for those with the disease, according to recent studies. High red meat intake has been associated with various health risks, including T2D and overall mortality. Studies suggest that reducing processed meat intake could prevent hundreds of thousands…

Read More

Biotech news from Roche, Amgen, Cassava

Stay updated on the latest science and politics in biotech with our newsletter. Adam Feuerstein is filling in for regular correspondents and reports that biotech companies are releasing all remaining news for the year before Thanksgiving, creating a hectic morning. The article is exclusive to STAT+ subscribers, offering in-depth analysis, newsletters, premium events, and news…

Read More

Mosquito-borne diseases are on the rise—here’s how collecting mozzies in your backyard can help science

Mosquitoes and mosquito-borne diseases are becoming more prevalent in Australia, with hundreds of types of mosquitoes posing health risks. Health authorities track mosquitoes to provide early warnings of disease risks, but citizen scientists are stepping in to help. The Mozzie Monitors program engages participants to monitor mosquito populations and contribute valuable data. By combining citizen…

Read More

Bacteria modify their ribosomes in response to the antibiotics

The research published in Nature Communications shows that bacteria can modify their ribosomes when exposed to antibiotics, potentially leading to antibiotic resistance. Escherichia coli was studied after exposure to streptomycin and kasugamycin, which target ribosomes to prevent protein production. The study found that the bacteria developed new ribosomes lacking chemical tags where antibiotics bind, making…

Read More
Advertise here
error: Content is protected !!